Alan Heldman

	WikiDoc Resources for Alan Heldman
Articles
Most recent articles on Alan Heldman Most cited articles on Alan Heldman Review articles on Alan Heldman Articles on Alan Heldman in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Alan Heldman Images of Alan Heldman Photos of Alan Heldman Podcasts & MP3s on Alan Heldman Videos on Alan Heldman
Evidence Based Medicine
Cochrane Collaboration on Alan Heldman Bandolier on Alan Heldman TRIP on Alan Heldman
Clinical Trials
Ongoing Trials on Alan Heldman at Clinical Trials.gov Trial results on Alan Heldman Clinical Trials on Alan Heldman at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Alan Heldman NICE Guidance on Alan Heldman NHS PRODIGY Guidance FDA on Alan Heldman CDC on Alan Heldman
Books
Books on Alan Heldman
News
Alan Heldman in the news Be alerted to news on Alan Heldman News trends on Alan Heldman
Commentary
Blogs on Alan Heldman
Definitions
Definitions of Alan Heldman
Patient Resources / Community
Patient resources on Alan Heldman Discussion groups on Alan Heldman Patient Handouts on Alan Heldman Directions to Hospitals Treating Alan Heldman Risk calculators and risk factors for Alan Heldman
Healthcare Provider Resources
Symptoms of Alan Heldman Causes & Risk Factors for Alan Heldman Diagnostic studies for Alan Heldman Treatment of Alan Heldman
Continuing Medical Education (CME)
CME Programs on Alan Heldman
International
Alan Heldman en Espanol Alan Heldman en Francais
Business
Alan Heldman in the Marketplace Patents on Alan Heldman
Experimental / Informatics
List of terms related to Alan Heldman

Alan W. Heldman, M.D. (1962-) is an American interventional cardiologist.

Heldman graduated from Harvard College, University of Alabama School of Medicine, and completed residency and fellowship training at Johns Hopkins University School of Medicine. He held positions on the faculty of Johns Hopkins from 1995 to 2007. In 2007 he became Clinical Chief of Cardiology at the University of Miami, Leonard M. Miller School of Medicine.

He published one of the first studies showing that a drug-coated stent (now known as a drug-eluting stent) could prevent restenosis¹. His research interests include delivery of stem cells to the heart for repair of myocardial infarction².

His clinical interests include high risk and complex coronary intervention, and treatment of hypertrophic cardiomyopathy, including with alcohol septal ablation³.

References

1) Heldman A, Cheng L, Jenkins G, Heller P, Kim D, Ware M, Nater C, Hruban R, Rezai B, Abella B, Bunge K, Kinsella J, Sollott S, Lakatta E, Brinker J, Hunter W, Froehlich J (2001). "Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.". Circulation 2001 May 8;103(18):2289-95. PMID 11342479

2) Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11474-9. PMID: 16061805

3) Heldman AW, Wu KC, Abraham TP, Cameron DE. Myectomy or alcohol septal ablation: surgery and percutaneous intervention go another round. J Am Coll Cardiol. 2007 Jan 23;49(3):358-60. PMID: 17239718